SOPH News and Press, SOPHiA GENETICS SA

2026-03-03 16:03:35 ET Mark Massaro from BTIG issued a price target of $7.00 for SOPH on 2026-03-03 19:23:00. The adjusted price target was set to $7.00. At the time of the announcement, SOPH was trading at $4.1. The overall price target consensus is at $7.00 with high p...

2026-03-03 12:32:26 ET SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call March 3, 2026 8:00 AM EST Company Participants Kellen Sanger - Head of Strategy and Investor Relations Jurgi Camblong - Co-Founder, CEO & Director Ross Muken - President George Cardoza...

2026-03-03 09:26:15 ET Image source: The Motley Fool. March 3, 2026, 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-03-03 07:38:17 ET More on SOPHiA Genetics Seeking Alpha’s Quant Rating on SOPHiA Genetics Historical earnings data for SOPHiA Genetics Financial information for SOPHiA Genetics Read the full article on Seeking Alpha For further details see...

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results PR Newswire BOSTON and ROLLE, Switzerland , March 3, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the fourth quarte...

2026-03-02 17:33:36 ET SOPHiA GENETICS S.A. (SOPH) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in SOPH stock price following earnings has averaged ±8.79% , with a median of 6.38%. ...

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference PR Newswire BOSTON and ROLLE, Switzerland , Feb. 25, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced that leadership will prese...

2026-02-18 23:05:09 ET This article is part of a series that provides an ongoing analysis of the changes made to Generation Investment Management’s 13F portfolio on a quarterly basis. It is based on Al Gore’s regulatory 13F Form filed on 02/12/2026. Please visit our ...

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 PR Newswire BOSTON and ROLLE, Switzerland , Feb. 17, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it ...

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems PR Newswire BOSTON and ROLLE, Switzerland , Feb. 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medic...